Beyond the buzz...

Having worked at the intersection of digital and pharma since 2008 (before it was sexy), I've had the opportunity to engage many talented executives trying to bring digital into an often risk-averse and 'traditional' corporate environment.


With lots of buzz around digital, some of the most common frustrations and concerns expressed by these executives include:


- skepticism from the 'core' business about the impact of digital

- fear of wasting budgets and resources on digital projects

- taking too long to evaluate digital opportunities

- not getting 'C-Suite' buy-in and approvals for investments

- not generating tangible results from digital projects and pilots


Do any of these sound familiar? Am I missing any BIG ones?


The good news is that I'm seeing more and more executives 'crack the nut' on how to successfully introduce digital into a non-digital environment (hint: it doesn't involve complex pharma-style business cases)

Recent Posts

See All

“Why should we invest in a digital therapeutic when it will never come close to generating the revenue we make from our drug portfolio? Why not reinvest into R&D to find the next blockbuster drug, whi

“It’s been 3 years of strategizing, ideating and experimenting with very little impact - unfortunately, our digital health folks have lost some credibility with the rest of the business” This unfortun

Imagine going for a hike and accidentally falling into a deep hole you can’t climb out of. You look up but all you see is blue sky and the surrounding wall of ground and dirt. Out of the blue, two peo